Jump to: navigation, search

Cardiovascular Disease Risk Assessment

Basic Facts

Stage of development

Implemented

Potential or current usage

This measure has been part of the PHO Performance Programme's National Indicator Set since 1 July 2008 and is used to determine what proportion of the population eligible for a CVD risk assessment have had their risk recorded in the past 5 years.

Brief overview of the measure

General description

This measure focuses on what proportion of the population eligible for a CVD risk assessment have had their risk recorded in the past 5 years.

Rationale for selection

A Cardiovascular Risk Assessment (CVRA) is a tool for identifying individuals at high risk of a cardiovascular event (e.g. stroke, heart attack or angina) and enables health carers to provide appropriate patient management and support. Cardiovascular disease (CVD) is the leading cause of death in New Zealand - preventative treatment can increase life expectancy and quality of life for patients at risk of CVD.

Domain(s) of qualitY

Effectiveness, Efficiency

Application and interpretation of the measure

Stated intent of the measure

Ensuring people who are at risk of having cardiovascular disease are identified so that appropriate interventions can be introduced.

Level of health care delivery/setting

This measure is currently reported by the PHO Performance Programme to PHO level although use of this measure to monitor practice and patient level performance is also possible.

Target population

Males of Māori, Pacific or Indian sub-continent ethnicity aged 35 to 74 years Females of Māori, Pacific or Indian sub-continent ethnicity aged 45 to 74 years Males of any other ethnicity aged 45 to 74 years Females of any other ethnicity aged 55 to 74 years

Stratification by vulnerable populations

The PHO Performance Programme currently uses this measure to monitor at both a total PHO enrolled population level (all PHO enrolled eligible patients) and a high need PHO enrolled population level (whereby high need is identified as Māori, Pacific Island and/or Decile 9 or 10)

Associated incentives

This measure is currently funded through the PHO Performance Programme both at a total population level and a high need level.

Calculation of the measure

Output of calculation

Percentage of elgible patients enrolled in a PHO that have had a CVD risk assessment in the past 5 years.

Numerator description

Number of enrolled people within the eligible population who have had a CVD risk recorded in the past 5 years.

Denominator description

Number of enrolled people in the PHO who are eligible for a CVD risk assessment.

Time period

5 years.

Criteria/standard for optimal performance

Every practice within a PHO should have a process in place for assessing CVD risk for eligible patients. The PHO Performance Programme goal (to be achieved over a 5 year period) is: 80% or more of a PHO’s target population have been assessed for their risk of developing cardiovascular disease.

Data source

PHO Clinical Performance Indicator Report and PHO patient enrolment registers.

Method of extraction

The link below will take you to the document that defines how the measure is calculated - see 'CVD Risk Assessment' section of the Indicator Definitions for PHOs document. [1](http://www.dhbnz.org.nz/Site/SIG/pho/Operational-Documents.aspx )

Appraisal of the measure

Development approach

This measure was developed by the PHO Performance Programme (which consists of an Advisory Group (refer to following link for current membership list: http://www.dhbnz.org.nz/Site/SIG/pho/PHO/Membership-List.aspx), a Governance Group (refer to following link for current membership list: http://www.dhbnz.org.nz/Site/SIG/pho/PHO/Governance-Group-Membership-List.aspx), and support team.

Other items

Owner details

Reference number

826

Date of entry to library

2012-05-31 11:21:04

Owner (Organisation name)

PHO Performance Programme

Owner (Email contact)

phoperformanceprogramme@dhbnz.org.nz

Creator (Organisation name)

PHO Performance Programme

Creator (Email contact)

phoperformanceprogramme@dhbnz.org.nz